Alan Zaccaria, MD
Plastic SurgeonAlan Zaccaria, MD, FACS
Alan Zaccaria, MD, FACS, is a double board certified Plastic Surgeon, in private practice in Little Silver, New Jersey. Dr. Zaccaria has expertise in breast reconstruction, breast implants, general reconstructive surgery, facial surgery, cosmetic surgery, skin cancer, botox & injectibles, comprehensive wound care, and wound care products. He also serves as a medicolegal expert. Dr. Zaccaria is a Fellow of the American College of Surgeons, and an active member of the American Society of Plastic Surgeons. He also has membership in a variety of other prestigious societies. He has served as the President of the Monmouth County Medical Society (New Jersey), and is currently the President of the Medical Staff, Chief of Plastic Surgery, and the Surgical Director of the Comprehensive Wound Care Center at Jersey Shore University Medical Center, Neptune, New Jersey. (This is me - Update Profile)
| Unspecified - present | Plastic Surgeon Alan Zaccaria, MD, FACS |
|---|
GLG Study Groups with Alan Zaccaria, MD(?)
| Study Group Name | Members |
|---|---|
| Breast Implant Surgeons (US) | 100 |
| Juvederm Users: Cosmetic Dermatologists (US) | 126 |
| Restylane Users (US) | 90 |
| Physicians who Implant Alloderm Grafts (US) | 65 |
GLG NewsSM Analyses by Alan Zaccaria, MD(?)
Over the past few years, noninvasive cosmetic procedures have skyrocketed. Soft tissue injectable fillers are among those procedures that are rapidly growing. Up until now, hyaluronic acid (HA) fillers have been the mainstay. With the emergence of Envolence, we have a new twist on...
Only FDA approved fillers administered by experienced, licensed physicians should be injected into patients. Also, the small volumes that are used today should not pose systemic problems that were seen in this article.
It is not unexpected that Medicis is expanding into the "Botox" business since its rival company, Allergan, has a monopoly on the market. Allergan also has Juviderm, which competes directly with Restylane, the hit product by Medicis. This will place Medicis back into the competitive market...
Blue Sky has not been able to capture significant market share. VAC, by KCI has cornered the market of negative pressure wound therapy.
GLG InstituteSM Seminars with Alan Zaccaria, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Alan Zaccaria, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms